Literature DB >> 7516659

Inhibition of nitric oxide synthase by antineoplastic anthracyclines.

D Luo1, S R Vincent.   

Abstract

Nitric oxide synthase, the enzyme responsible for the synthesis of nitric oxide and citrulline from arginine, was potently inhibited by the anthracycline antibiotics doxorubicin (Ki = 24 microM) and aclarubicin (Ki = 50 microM). These drugs were non-competitive inhibitors with respect to arginine. This action on nitric oxide synthase may explain some of the cardiovascular and cytotoxic actions of these chemotherapeutic drugs.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7516659     DOI: 10.1016/0006-2952(94)90088-4

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  4 in total

1.  Possible mechanisms for induction of oxidative stress and suppression of systemic nitric oxide production caused by exposure to environmental chemicals.

Authors:  Yoshito Kumagai; Nobuhiro Shimojo
Journal:  Environ Health Prev Med       Date:  2002-09       Impact factor: 3.674

Review 2.  Dexrazoxane for the prevention of cardiac toxicity and treatment of extravasation injury from the anthracycline antibiotics.

Authors:  James H Doroshow
Journal:  Curr Pharm Biotechnol       Date:  2012-08       Impact factor: 2.837

3.  Neuronal nitric oxide synthase is a key factor in doxorubicin-induced toxicity to rat-isolated cortical neurons.

Authors:  Miguel Angelo Lopes; Andreas Meisel; Félix Dias Carvalho; Maria de Lourdes Bastos
Journal:  Neurotox Res       Date:  2009-11-19       Impact factor: 3.911

4.  Differential roles of nitric oxide synthase isozymes in cardiotoxicity and mortality following chronic doxorubicin treatment in mice.

Authors:  Shiwei Deng; Anke Kruger; Albrecht Schmidt; Annegret Metzger; Tiandong Yan; Ute Gödtel-Armbrust; Gerd Hasenfuss; Friedrich Brunner; Leszek Wojnowski
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2009-03-24       Impact factor: 3.000

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.